Anila Duni
Overview
Explore the profile of Anila Duni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
391
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Georgopoulos C, Duni A, Stamellou E, Kitsos A, Gouva C, Dounousi E
Hemodial Int
. 2024 Oct;
29(1):6-16.
PMID: 39422162
Introduction: Phosphate binders are commonly used in patients receiving kidney replacement therapy (KRT), aiming to reduce and maintain serum phosphorus. Chronic kidney disease-mineral and bone disorder has been linked to...
2.
Duni A, Kitsos A, Bechlioulis A, Lakkas L, Markopoulos G, Tatsis V, et al.
Int J Mol Sci
. 2024 Sep;
25(17).
PMID: 39273110
The role of immune system components in the development of myocardial remodeling in chronic kidney disease (CKD) and kidney transplantation remains an open question. Our aim was to investigate the...
3.
Bolignano D, Greco M, Presta P, Duni A, Zicarelli M, Mercuri S, et al.
Blood Purif
. 2024 Aug;
53(10):824-837.
PMID: 39111290
Introduction: Uremic patients exhibit remarkably increased rates of mortality and cardiovascular (CV) events, but risk prediction in this setting remains difficult. Systemic mitochondrial dysfunction is pervasive in end-stage kidney disease...
4.
Bolignano D, Greco M, Presta P, Duni A, Zicarelli M, Mercuri S, et al.
J Nephrol
. 2024 Aug;
37(7):1863-1870.
PMID: 39102184
Background: Mortality and cardiovascular (CV) risk prediction in individuals with end-stage kidney disease (ESKD) on chronic hemodialysis (HD) remains challenging due to the multitude of implicated factors. In a multicenter...
5.
Koutlas V, Tzalavra E, Tatsis V, Pappas C, Vovlianou S, Bellos S, et al.
World J Transplant
. 2024 Jul;
14(2):90825.
PMID: 38947968
Background: Kidney transplantation leads to continuous improvement in the survival rates of kidney transplant recipients (KTRs) and has been established as the treatment of choice for patients with end-stage kidney...
6.
Duni A, Greco M, Presta P, Arena R, Pappas E, Lakkas L, et al.
Biomolecules
. 2023 Nov;
13(11).
PMID: 38002345
Background: Despite patients undergoing chronic hemodialysis (HD) being notoriously prone to adverse cardiovascular (CV) events, risk prediction in this population remains challenging. miRNA 122-5p, a short, non-coding RNA predominantly involved...
7.
Lakkas L, Naka K, Bechlioulis A, Duni A, Moustakli M, Balafa O, et al.
Echocardiography
. 2023 May;
40(7):600-607.
PMID: 37229577
Aim: To investigate abnormalities in myocardial strain and classic echocardiographic indices and coronary flow reserve (CFR), in younger versus older CKD patients. Methods: Sixty consecutive CKD patients (<60 years old...
8.
Duni A, Kitsos A, Bechlioulis A, Markopoulos G, Lakkas L, Baxevanos G, et al.
Biomedicines
. 2023 May;
11(4).
PMID: 37189647
Method: A total of 39 stable males with CRS-2 and 24 male CKD patients matched for eGFR (CKD-EPI) were enrolled. A selected panel of immune cell subsets was measured by...
9.
Bolignano D, Greco M, Presta P, Duni A, Vita C, Pappas E, et al.
Clin Kidney J
. 2023 May;
16(5):868-878.
PMID: 37151423
Background: Chronic hemodialysis (HD) patients exhibit severe morpho-functional cardiac alterations, putting them at a high risk of death and adverse cardiovascular (CV) outcomes. Despite the fact that an unbalanced expression...
10.
Roumeliotis S, Duni A, Vaios V, Kitsos A, Liakopoulos V, Dounousi E
Nutrients
. 2022 Mar;
14(5).
PMID: 35267901
Chronic Kidney Disease (CKD) patients are at high risk of presenting with arterial calcification or stiffness, which confers increased cardiovascular mortality and morbidity. In recent years, it has become evident...